510(k) Report

PMA · Approved

Approved

VENTANA MMR RxDx Panel

P210001PMAApproved Aug 17, 2021207-day reviewClass III21 CFR 864.1860

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ventana Medical Systems, Inc. (Roche Tissue Diagnostics) · QNH Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

Approved on Aug 17, 2021 through premarket approval, which rests on the device’s own clinical evidence after a 207-day review.

Decided
Aug 17, 2021
Review
207 days
Class
Class III
Product code
QNH
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P210001 has 16 supplements since 2022: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2022: 72023: 32024: 32025: 12026: 2
2022high 7 (2022) · low 1 (2025)2026
View FIG. 1 as a table
YearSupplements approved
20227
20233
20243
20251
20262
FIG. 1 — Supplements to P210001, 2022–2026Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QNH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All QNH devices

QNH Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · QNH

4in 2025

2021: 22022: 102023: 52024: 42025: 42026 (partial year): 5
2007high 10 (2022) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QNH

Too few QNH 510(k)s in any year since 2007 to give a median.

Recalls per year · QNH

No recall names QNH since 2007.

Adverse event reports per year · QNH

1in 2023

2023: 1
2007high 1 (2023) · low 0 (2007)2025

MAUDE reports naming product code QNH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20212—00
202210—00
20235—01
20244—00
20254—00
20265—0—
Cite this page

510(k) Report. “P210001: VENTANA MMR RxDx Panel.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/P210001

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026